Fisher & Paykel Healthcare to Announce Half Year Results

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced today that it intends to release on Thursday 20 November its financial results for the six months ended 30 September 2008.  The release will be issued shortly after 9:00am NZDT, 7:00am AEDT (3:00pm USEST, Wednesday 19 November).

Fisher & Paykel Healthcare will host a conference call to review the results and to discuss the outlook for the remainder of the 2009 financial year.  The conference call is scheduled to begin at
10:00am NZDT, 8:00am AEDT (4:00pm USEST, Wednesday 19 November) and will be broadcast simultaneously over the Internet.

To listen to the webcast access the company’s website at  Please allow extra time prior to the webcast to visit the site and download the streaming media software required.  An online archive of the event will be available approximately two hours after the webcast and will remain onsite for two weeks.

Intending participants may register for the conference call prior to the event, using this link:  Once registered, participants will be assigned a conference Passcode and user PIN.  On the day of the conference registered participants can dial in to one of the numbers below and use their codes for instant access to the conference. Alternatively, dial in to one of the numbers below a few minutes prior to the scheduled call time and identify yourself to the operator:

New Zealand Toll Free  0800 449 118
Australia Toll Free  1800 555 616
USA Toll Free  1866 369 4113
International  +61 3 9221 4420

An audio replay of the conference call will be available approximately 60 minutes after the call and will be accessible for two weeks at +61 3 9221 4752, access code 006001.

About Fisher & Paykel Healthcare
Fisher   &  Paykel   Healthcare   is  a  leading   designer,   manufacturer   and  marketer   of  heated humidification products and systems for use in respiratory care, acute care and the treatment of obstructive  sleep apnea. The company’s products are sold in over 110 countries worldwide.   For more information about the company visit

Contact: Michael Daniell MD/CEO on +64 9 574 0161 or Tony Barclay CFO on +64 9 574 0119.